| (E)-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-Epoxy-5-hydroxy-4-methylhexyl)tetrahydro-3,4-dihydroxy-beta-methyl-2H-pyran-2-crotonic acid, ester with 9-hydroxynonanoic acid |
| 115074-43-6 |
| 12650-69-0 |
| 1jzs |
| 5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2E,8[2S,3S(1S,2S)]]-L-talonon-2-enonic acid 8-carboxyoctyl ester |
| 6-Chloro-2,4-dimethoxy pyrimidine |
| 62916-63-6 |
| 8-Carboxyoctyl (E)-4-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylcrotonat |
| 80558-54-9 |
| 9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic acid |
| 9-((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)-tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoic acid |
| 9-((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoic acid |
| 9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)-oxiranylmethyl]-tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)-nonanoic acid |
| 9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid calcium salt |
| 9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt |
| 9-({(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid |
| 9-(4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)-tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoic acid |
| 9-(4-{3,4-Dihydroxy-5-[3-(2-hydroxy-1-methyl-propyl)-oxiranylmethyl]-tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)-nonanoic acid (Mupirocin) |
| 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl] oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid |
| 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methyl-propyl]oxiran-2-yl]methyl]tetrahydropyran-2-yl]-3-methyl-but-2-enoyl]oxynonanoic acid |
| 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid |
| 9-{[(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-{[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl}oxan-2-yl]-3-methylbut-2-enoyl]oxy}nonanoic acid |
| AB0010371 |
| AB01563109_01 |
| AC1L9JV4 |
| AK544341 |
| AKOS015994756 |
| AOB6353 |
| AS-11580 |
| Bactoderm |
| Bactroban |
| Bactroban (TN) |
| Bactroban Nasal |
| Bactroban Ointment |
| BC656995 |
| BDBM50290686 |
| BIDD:GT0320 |
| BRD-K15262564-001-06-9 |
| BRL 4910A |
| BRL-4910A |
| C11758 |
| C26H44O9 |
| CAS-12650-69-0 |
| CCG-213522 |
| Centany (TN) |
| CHEBI:7025 |
| CHEBI:94519 |
| CHEMBL719 |
| cid_446596 |
| CPD000471888 |
| D01076 |
| D0GX863OA5 |
| DB00410 |
| DSSTox_CID_26438 |
| DSSTox_GSID_46438 |
| DSSTox_RID_81614 |
| DTXSID0046438 |
| HMS2234E20 |
| HMS3259L05 |
| HMS3712K03 |
| HY-B0958 |
| KS-5137 |
| LS-177887 |
| M-8680 |
| M2955 |
| MFCD01711620 |
| MFCD11977847 |
| MINDHVHHQZYEEK-HBBNESRFSA-N |
| MLS001074711 |
| MolPort-003-666-882 |
| MRC |
| Mupirocin |
| Mupirocin (USP/INN) |
| Mupirocin [USAN:USP:INN:BAN] |
| mupirocin calcium salt |
| mupirocin lithium salt |
| Mupirocin Neo-Sensitabs |
| Mupirocin, >=92% (HPLC), powder |
| Mupirocin, 14C-Labeled |
| Mupirocin, Antibiotic for Culture Media Use Only |
| Mupirocin, Pseudomonic Acid A |
| Mupirocin, United States Pharmacopeia (USP) Reference Standard |
| Mupirocin,(S) |
| Mupirocina |
| Mupirocina [Spanish] |
| Mupirocine |
| Mupirocine [French] |
| Mupirocinum |
| Mupirocinum [Latin] |
| NC00620 |
| NCGC00164554-03 |
| NCGC00164554-05 |
| Nonanoic acid, 9-((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)-, (2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))- |
| NSC-759182 |
| NSC759182 |
| Pharmakon1600-01505706 |
| Plasimine |
| Pseudomonic acid |
| Pseudomonic acid A |
| Pseudomonic acid A lithium salt |
| S4297 |
| SAM002589979 |
| SBI-0206892.P001 |
| SC-16672 |
| SCHEMBL1027618 |
| SCHEMBL3291 |
| SMR000471888 |
| SR-05000001947 |
| SR-05000001947-1 |
| SR-05000001947-2 |
| Tox21_112183 |
| trans-Pseudomonic acid |
| Turixin |
| UNII-D0GX863OA5 |
| ZINC4102194 |
